par 545

Pill imprint par 545 has been identified as Ranitidine hydrochloride 300 mg.

Ranitidine is used in the treatment of stomach ulcer; gerd; gastric ulcer maintenance treatment; indigestion; erosive esophagitis (and more), and belongs to the drug class H2 antagonists. There is no proven risk in humans during pregnancy.

Ranitidine 300 mg is not subject to the Controlled Substances Act.
See also related documents.

Ranitidine hydrochloride Images

Imprint:
par 545
Strength:
300 mg
Color:
Yellow
Size:
14.00 mm
Shape:
Elliptical / Oval
Availability:
Rx and/or OTC
Inactive Ingredients:
FD&C Yellow No. 6
hypromellose
lactose monohydrate
magnesium stearate
microcrystalline cellulose
pregelatinized corn starch
titanium dioxide
triethyl citrate
ferric oxide yellow
Drug Class:
H2 antagonists
Pregnancy Category:
B - No proven risk in humans
CSA Schedule:
N - Not a controlled drug
Manufacturer:
Par Pharmaceutical Inc.
National Drug Code (NDC):
49884-0545
Other Manufacturers / Repackagers:
NDC CodeManufacturer / Repackager
62584-0253 Amerisource Health Services
54868-4350 Physicians Total Care Inc (repackager)
49999-0428 Lake Erie Medical and Surgical Supply (repackager)
68115-0404 Dispensexpress Inc (repackager)
63874-0428 Altura Pharmaceuticals Inc (repackager)
66267-0452 Nucare Pharmaceuticals Inc (repackager)

Note: Inactive ingredients may vary.

View Drug DetailsPrint Page

Ranitidine hydrochloride 300 mg par 545  Front
Ranitidine hydrochloride 300 mg par 545  Back
Ranitidine hydrochloride 300 mg par 545
Ranitidine hydrochloride 300 mg par 545
Advertisement
Search Again

Search by Imprint, Shape or Color

Note: All fields optional. Use the pill finder to identify medications by visual appearance or name.

Imprint:
Color:
Shape:

Search by Drug Name

Drug Name:

Search by National Drug Codes (NDC)

Did you find this page helpful? Yes No

(web6)